5-sulfanylmethyl-pyrazolo [1,5-a] pyrimidin-7-ol derivatives as CXCR2 antagonists

Details for Australian Patent Application No. 2007324472 (hide)

Owner Novartis AG

Inventors Hunt, Peter; Watson, Simon James; Spanka, Carsten; Porter, David; Press, Neil John

Agent Davies Collison Cave

Pub. Number AU-A-2007324472

PCT Pub. Number WO2008/062026

Priority 06124682.3 23.11.06 EP

Filing date 21 November 2007

Wipo publication date 29 May 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/522 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/062026 Priority application(s): WO2008/062026

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324478-An automatic miniature injector and sample-taker device for medical use

2007324467-Vaginal delivery system for mirtazapine